Superiority of Direct Oral Anticoagulants over Vitamin K Antagonists in Oncological Patients with Atrial Fibrillation: Analysis of Efficacy and Safety Outcomes

Background and aim. Cancer and atrial fibrillation (AF) may be associated, and anticoagulation, either with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), is necessary to prevent thromboembolic events by reducing the risk of bleeding. The log incidence rate ratio (IRR) and 95% c...

Descripción completa

Detalles Bibliográficos
Autores principales: Parrini, Iris, Lucà, Fabiana, Rao, Carmelo Massimiliano, Parise, Gianmarco, Micali, Linda Renata, Musumeci, Giuseppe, La Meir, Mark, Colivicchi, Furio, Gulizia, Michele Massimo, Gelsomino, Sandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572823/
https://www.ncbi.nlm.nih.gov/pubmed/36233581
http://dx.doi.org/10.3390/jcm11195712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572823/
https://www.ncbi.nlm.nih.gov/pubmed/36233581
http://dx.doi.org/10.3390/jcm11195712

Ejemplares similares